Australia’s number one dermatologist-recommended skincare brand, La Roche-Posay, has unveiled the latest innovation in its iconic Effaclar range: the Effaclar A.Z. Gel-Cream. Specially formulated for adult blemish-prone skin, this advanced gel-cream not only targets breakouts but also addresses visible signs of ageing—making it a game-changing multitasker for complex skin concerns.
Clinically tested to reduce recurring breakouts in as little as seven days, Effaclar A.Z. Gel-Cream features a synergistic blend of dermatologically backed ingredients, including 10% Azelaic Acid, Salicylic Acid and Hyaluronic Acid. The formula helps reduce blackheads, whiteheads, and post-blemish pigmentation, while also improving skin firmness and hydration. Additional calming and restorative ingredients like Panthenol and Endophytol help to repair the moisture barrier and reduce redness—delivering clearer, healthier-looking skin without irritation.
In a recent clinical evaluation, 72% of users saw a reduction in pigmented marks within one week, and 98% reported improved skin firmness over four weeks. Dermatologists are praising the dual-action formula, with Dr JoAnn See noting, “Managing adult blemish-prone skin requires a thoughtful and comprehensive approach,” while Dr Cara McDonald called it “a significant step forward.” Rachel McAdam, Head of Medical Relations at La Roche-Posay, adds: “We’re thrilled to introduce a powerful new addition to our Effaclar family that balances efficacy and tolerance.”
The Effaclar A.Z. Gel-Cream (40ml, RRP $65.95) is suitable for all skin tones and can be used morning and night, followed by SPF during the day. It is available at Chemist Warehouse stores and online.
Leave a Reply